Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,801Revenue $M20.7Net Margin (%)-421.3Z-Score11.2
Enterprise Value $M2,706EPS $-2.1Operating Margin %-438.9F-Score3
P/E(ttm))0Cash Flow Per Share $-1.6Pre-tax Margin (%)-470.9Higher ROA y-yN
Price/Book35.010-y EBITDA Growth Rate %0Quick Ratio5.5Cash flow > EarningsY
Price/Sales1325-y EBITDA Growth Rate %0Current Ratio5.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-219.0ROA % (ttm)-52.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-96.0Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M43.4ROI % (ttm)-221.3Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ANACJean-Marie Eveillard 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
($4.32)
$ 64.4993%Sold Out0
ANACJean-Marie Eveillard 2012-12-31 Buy $4.6 - $6.81
($5.55)
$ 64.4991%New holding92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Plattner Jacob jSenior VP, Research 2015-04-15Sell8,920$62.818.23 view
Maples Kirk RSVP, Program Management 2015-04-01Sell600$57.0219.22 view
Parker Geoffrey M.Executive Vice President & CFO 2015-03-23Buy3,000$52.4329.66 view
BERNS PAUL LPresident and CEO 2015-03-19Sell37,500$56.0721.24 view
Plattner Jacob jSenior VP, Research 2015-03-16Sell8,920$55.622.27 view
Zane LeeSVP and Chief Medical Officer 2015-03-16Sell12,000$56.4420.45 view
Chanda SanjaySVP, Drug Development 2015-03-04Sell5,000$4551.07 view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2015-03-03Sell9,000$43.8854.92 view
Plattner Jacob jSenior VP, Research 2015-03-02Sell6,875$44.0254.43 view
Maples Kirk RSVP, Program Management 2015-03-02Sell600$43.9554.68 view

Press Releases about ANAC :

    Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Anacor Pharmaceuticals’ Q4 Was A Solid One For Investors Mar 16 2015 
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 
    This Week's Top Insider Buys Jun 19 2013 
    comment on ANAC Mar 16 2013 
    Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
    Weekly CFO Buys Highlight: GSVC, SHO, YAVY, CMCSA, ANAC May 16 2011 

    More From Other Websites
    Nasdaq stocks posting largest percentage increases Apr 17 2015
    Two Biotech Buyout Candidates Apr 14 2015
    Insiders are buying these stocks Mar 31 2015
    The Best and Worst Medalists of 2015's First Quarter Mar 30 2015
    Abercrombie & Fitch Co., Anacor Pharmaceuticals Inc and Civeo Corp (CVEO): Latest Insider Action Mar 26 2015
    ANACOR PHARMACEUTICALS, INC. Financials Mar 21 2015
    ANACOR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 16 2015
    Company News for March 16, 2015 - Corporate Summary Mar 16 2015
    Anacor Pharmaceuticals hits record high on earnings Mar 13 2015
    Anacor Pharmaceuticals Reports 2014 Fourth Quarter and Year-End Financial Results Mar 13 2015
    Anacor reports 4Q loss Mar 12 2015
    Anacor reports 4Q loss Mar 12 2015
    Anacor Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today Mar 12 2015
    Anacor Pharmaceuticals Announces Presentations at the American Academy of Dermatology Annual Meeting Mar 12 2015
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 12 2015
    Anacor Pharmaceuticals Announces Presentations at the American Academy of Dermatology Annual Meeting Mar 12 2015
    Anacor Pharmaceuticals Reports 2014 Fourth Quarter and Year-End Financial Results Mar 12 2015
    Q4 2014 Anacor Pharmaceuticals Inc Earnings Release - After Market Close Mar 12 2015
    Anacor Pharmaceuticals Announces 2014 Fourth Quarter and Year-End Financial Results Conference Call... Mar 05 2015
    Anacor Pharmaceuticals Announces 2014 Fourth Quarter and Year-End Financial Results Conference Call... Mar 05 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK